OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GZ3YL11

Real-time BOERSE MUENCHEN 17:25:56 24/05/2024 BST
7.57 EUR +6.62% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month-10.35%
1 month-6.95%
Date Price Change
24/05/24 7.57 +6.62%
23/05/24 7.1 -4.83%
22/05/24 7.46 +6.72%
21/05/24 6.99 -1.41%
20/05/24 7.09 -2.34%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 05:25 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GZ3YL1
ISINDE000GZ3YL11
Date issued 24/11/2022
Strike 254.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 10.2
Lowest since issue 0.242
Spread 0.03
Spread %0.40%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.1 USD
Average target price
372.4 USD
Spread / Average Target
+12.79%
Consensus